Levi & Korsinsky Reminds Cardlytics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - CDLX
NEW YORK, NY / ACCESS Newswire / March 17, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Cardlytics, Inc.(CDLX) Shareholders
NEW YORK , March 17, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cardlytics, Inc. (NASDAQ: CDLX). Shareholders who purchased shares of CDLX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
CDLX LAWSUIT ALERT: Levi & Korsinsky Notifies Cardlytics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESS Newswire / March 16, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Shareholders that lost money on Cardlytics, Inc.(CDLX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
NEW YORK, NY / ACCESS Newswire / March 15, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cardlytics To Contact Him Directly To Discuss Their Options
CDLX INVESTORS: Contact Robbins LLP for Information About the Lead Plaintiff Deadline in the Class Action Against Cardlytics, Inc.
SAN DIEGO, March 14, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Cardlytics, Inc. (NASDAQ: CDLX) securities between March 14, 2024 and August 7, 2024. Cardlytics operates an advertising platform in the U.S. and the U.K. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
Shareholders that lost money on Cardlytics, Inc. (CDLX) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
NEW YORK, March 13, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX) of a class action securities lawsuit.
Contact Levi & Korsinsky by March 25, 2025 Deadline to Join Class Action Against Cardlytics, Inc. (CDLX)
NEW YORK, NY / ACCESS Newswire / March 13, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Cardlytics To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Cardlytics between March 14, 2024 and August 7, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , March 13, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX) and reminds investors of the March 25, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Class Action Filed Against Cardlytics, Inc. (CDLX) Seeking Recovery for Investors - Contact The Gross Law Firm
NEW YORK , March 13, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cardlytics, Inc. (NASDAQ: CDLX). Shareholders who purchased shares of CDLX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Cardlytics, Inc. (CDLX) Q4 2024 Earnings Call Transcript
Cardlytics, Inc. (NASDAQ:CDLX ) Q4 2024 Results Conference Call March 12, 2025 5:00 PM ET Company Participants Nick Lynton - Chief Legal & Privacy Officer Amit Gupta - Chief Executive Officer Alexis DeSieno - Chief Financial Officer Conference Call Participants Luke Horton - Northland Securities Kyle Peterson - Needham Cal Bartyzal - Craig-Hallum Robert Coolbrith - Evercore ISI Operator Good afternoon, ladies and gentlemen, and welcome to the Cardlytics Fourth Quarter Fiscal Year 2024 Earnings Conference Call. At this time, all lines are in listen-only mode.
Cardlytics Announces Fourth Quarter and Full Year 2024 Financial Results
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced financial results for the fourth quarter and full year ended December 31, 2024. "While 2024 was a challenging year for Cardlytics, we nevertheless planted the seeds and refocused our efforts to get back on track for growth this year," said Amit Gupta, CEO of Cardlytics. "We remain grounded in our vision for long-term and sustainable growth. We are focused on strengthening our competitive moat through our efforts to modern.
